PadreLee.eth

I recall getting a ton of shit for this.

$AERO flows are being insanely optimized MEV-resistance is part of the whole REV model and the more its perfected the better the revenue I have displayed several data points in the past proving how Aerodrome's engine is several times more efficient than its peers Volume flows organically where its best serviced Its easy to see where we're heading once mainnet will be activated DAO tokens are going to 0, AERO on the other hand stands in a league of its own and I constantly feel the urge to grab more

Want to know your share of sAERO on @AerodromeFi ahead of the July launch? New dashboard that utilizes both of my veAERO and veVELO queries to show projected shares of sAERO: dune.com/jpn/saero-lead… This also shows the projected share of the new Momentum Fund. ✈️

🤔 $AERO definitely hasn’t been an easy hold… but it still remains the flagship for whale flows on @base Even on a weak market day, whales just dived in to BTFD — pushing $AERO to #1 across ALL Base tokens in 24H whale inflows 👀 📊 $AERO 24H onchain via @nansen_ai • Whale inflows: +$780K (2.6× avg) → strongest on Base • One smart HL trader bought 1.9M $AERO (~$778K) with zero sells • Exchange outflows: -$1.3M → supply moving off exchanges • Fresh wallets: +$437K → new capital still entering • ~$11.5M volume → still one of the most actively traded names on Base 🧠 What stands out • Whales aggressively buying weakness • Large buyers showing conviction despite shaky PA • Exchange outflows reinforcing the accumulation setup • Aerodrome Public Goods Fund continuing to programmatically buy back + lock $AERO → meaningful structural support • Even through volatility, $AERO still trades as the blue-chip DeFi proxy of Base 📌 TLDR $AERO may test patience… but the whale flows continue telling the same story. • whales buying weakness • strong liquidity • flagship Base positioning • institutional-sized accumulation In uncertain markets, capital usually rotates into established ecosystem leaders first — and $AERO continues proving it belongs in that category 👀 $0.40–$0.41 now looks like a strong zone to monitor / scale into if support continues holding. Markets choppy, 👀 still onchain — follow @Chyan for daily insights. 📶 Use discount code CHYAN via the link in my profile to access the best onchain alpha + flow dashboards on @nansen_ai.

$AERO flows dominate in many ways but here's an undeniable denominator that is probably the most important Blocktronics has an option that will allow you to see stablecoin flows over time A positive net inflow number is bearish for alts and vice versa Stablecoins are the backbone and the lifeblood of any blockchain He who captures the majority, dominates the market Aerodrome captures 56.6% of that market with ≈ 10.48B of flows in 30D with Uniswap capturing 4.24B as their runner up Swap efficiency is unmatched and hence the organic flow of stablecoins through their routers

$AERO is revisiting its 40c equilibrium price, but is that sharp drop from 54c to 40c justified Look at the relative performance of ETH/USDC vs AERO/USDC, what do you notice ? An almost exact price pattern which can immediately conclude that AERO is simply moving with Ethereum Nothing has changed in terms of fundamentals, if anything they are stronger than ever Just this epoch 1.5M of revenue has been accrued thus far and we're still 2 days away from conclusion AERO is the no-brainer DEX token to buy, don't get shaken out

$AERO making the play for $80 B+ capital. Base flywheel accelerating hard. This is why I’m all in on Aero. @base @AerodromeFi x.com/AerodromeFi/st…

My initial entry on $AORA is 0.08, I was down 50k+ on $AORA, hence my crashout on @AerodromeFi, but i kept holding and adding more, simply because despite the terrible launch, the fundamentals of @AtlasOraFi didn't change. @AerodromeFi ignition launches are notoriously terrible during the first few days, especially on launch day, where veAERO whales/voters heavily dump their supply. I was so bullish on @AtlasOraFi that i went against my own rule of never buying another @AerodromeFi ignition launch again, but i guess i should’ve stuck to it. Hopefully @AerodromeFi eventually fixes this broken launch model for future projects. That aside, $AORA is still an incredible project and checks many of the boxes i look for in long-term investments. They’ve been fully transparent through B1 @Blockworks regarding tokenomics and structure. So what is @AtlasOraFi? Put simply, it’s essentially Airbnb onchain better fees, onchain settlement, hosts earning more, guests paying less. A settlement layer for real-world commerce built on @base using EURC/USDC rails. As i’ve said before, i’m extremely bullish on projects building real-world companies using blockchain rails in ways that genuinely make sense. @AtlasOraFi is targeting the short-term rental and booking market with a more efficient and incentive-aligned model for both hosts and guests, in a multi-billion dollar industry. This is not some random meme coin. @AtlasOraFi already has real-world corporate structure in place: • AtlasOra Foundation (Panama) owns the smart contracts and governs the token • MasaOra Ltd (UK) operates the flagship marketplace under licence • Third-party licensed platforms pay 0.5% of associated revenue Another thing i heavily focus on for high conviction long-term bets is the team. The co-founders and the CFO previously worked as finance lead at @Expedia for over 6 years helping scale the business. @Expedia is a $26B company, leader of this market segment that they're targetting. That means the team is deeply experienced and well connected in the exact travel and booking market @AtlasOraFi is targeting. Right now: • $AORA sits around 2.5m circ mcap • Airbnb sits around 86b • Expedia around 26b And $AORA is going after this same market of short-term rental bookings and travel commerce with an experienced team and a structurally better model. To me, the asymmetry here is extremely attractive. Yes, the launch was awful. But even $VVV had an even worse launch on @AerodromeFi before eventually sending much higher. So i’m not letting the terrible day-one price action cloud my thesis. More info on @AtlasOraFi in the rest of the threa.

Aerodrome generates more revenue for its token holders than any other DEX. What's interesting is that it surpassed Uniswap in holders revenue despite Uniswap doing 3x more volume.

Aerodrome doing more revenue on @base than every other DEX onchain. Don't think anyone is ready for what's about to happen when Aero hits @ethereum mainnet.

That feels big Circle CEO discussing how deeply partnered they are with @AerodromeFi and how much they would like to continue to develop that partnership I've said it before, aero is tricky to invest in, but those of us who are in, seem to have a bright future

Production Markets are an entirely new financial primitive -- one that is only possible onchain. Predictive Allocation is how they come to life on Aero: the worlds first prediction-driven, real-time capital allocation, and revenue distribution mechanism.

🚨This protocol has been shared by several cancer patients online who claim it supported their recovery journey—especially as more people discuss the rise in rare cancers in recent years. Alternative wellness routine shared online: 🌅 Morning • Curcumin – 600mg • Zinc – 50mg • Milk Thistle • Serrapeptase – 120,000 IU • Fenbendazole – 1000mg 🌙 Night • Curcumin – 600mg • Berberine – 600mg • Quercetin – 500mg • Turkey Tail • Vitamin E • Fenbendazole – 1000mg • Ivermectin – 12mg (5 days/week) Visit: Ivermectincure.us & 👉@_Ivermectincure Always do your own research and consult a qualified healthcare professional before starting any supplement or medication routine. #Ivermectin #CancerCure #fenbendazole #CancerResearch

"Aerodrome is responsible for the highest $USDC transfer volume of any tracked app in crypto." "The innovation is happening. And Aerodrome is building the primitives, the liquidity primitives, the protocol primitives to make that possible." - @jerallaire, CEO of @circle

aerodrome does $87m in annual fees, distributes 100% to veAERO voters and LPs, trades at 4.80x price-to-fees. hyperliquid does $96m monthly but at $41B FDV. per dollar of market cap aerodrome returns 6x more to holders. the part that hasn't been priced: july ethereum mainnet launch via velodrome merge brings the protocol from base's $12b monthly volume into ethereum's $46b. if it captures even 10% of ethereum DEX flow, annual fees double. 50%+ market share on base already proven. the model works, the question is whether it travels. 8 weeks to find out.

$1+ $AERO before July update. It's value as a launchpad (see @pharos_network and now @AtlasOraFi) and ability to bring liquidity to newly listed long tail assets (RWA season needs this especially) is deeply underappreciated. Way higher.

🚨🚨 Cirujano del cáncer: "La ivermectina es MÁS SEGURA que una píldora de azúcar y la he visto revertir el cáncer en etapa 4"... "Tendrías que tomar mucho para hacerte daño"... La ivermectina también es: 🔹 Un medicamento ganador del Premio Nobel (2015) 🔹Llamada el segundo mayor avance médico después de la penicilina... 💊 12 acciones anticáncer conocidas: 1. Inhibe la vía WNT/β-catenina: detiene la proliferación de células cancerosas. 2. Induce la apoptosis: desencadena la muerte programada de las células cancerosas. 3. Bloquea las proteínas transportadoras de importina α/β, lo que impide la replicación de células cancerosas. 4. Inhibe la enzima PAK1: reduce la inflamación y la progresión tumoral. 5. Antiangiogénico: detiene la formación de nuevos vasos sanguíneos en los tumores. 6. Modulador del sistema inmunológico: mejora el reconocimiento de las células cancerosas. 7. Disruptor de la autofagia: interfiere con las estrategias de supervivencia de las células cancerosas. 8. Se dirige a las células madre del glioblastoma: eficaz en cánceres cerebrales. 9. Inhibe la respiración mitocondrial: corta el suministro de energía a los tumores. 10. Interrumpe la señalización de mTOR, lo que ralentiza el crecimiento celular. 11. Supera la resistencia a la quimioterapia: hace que la quimioterapia sea más efectiva. 12. Propiedades antivirales: potencialmente útiles para cánceres relacionados con virus (como el VPH).

🚨🚨 83-year-old woman with stage 4 breast cancer that had metastasized to the liver, spine, and bones... Generally, a death sentence. For eight months, she took a daily dose of 222 mg of fenbendazole, which normalized her liver enzymes. The tumor marker dropped from 316 to 36... No abnormal metabolic activity indicating cancer was detected... Dr. John Campbell. 💊 FENBENDAZOLE – 12 Known Anticancer Actions: 1. Microtubule disruption: prevents cancer cells from dividing. 2. Inhibits glucose uptake: deprives cancer cells of energy. 3. Activates the p53 tumor suppressor gene, which helps eliminate damaged cells. 4. Triggers apoptosis (cell death), especially in lung, colon, and prostate cancer. 5. Inhibits metastasis: prevents cancer from spreading. 6. Increases oxidative stress in cancer cells, making them more vulnerable. 7. Immune modulator: may help the immune system attack tumors. 8. Blocks angiogenesis: prevents tumors from generating a blood supply. 9. Depletes glutathione in tumors, weakening their defenses. 10. Suppresses the AKT signaling pathway, involved in cell survival. 11. Restores normal cell cycle regulation: prevents uncontrolled growth. 12. Synergistic with other natural agents (e.g., CBD, curcumin, vitamin D) Follow @ZakariaMDv3 . Thanks

An absolute must read below for anyone anxiously awaiting the launch of Aero in July. 🛫

🚨 BREAKING NEWS: New Cancer Protocol Using Ivermectin, Ketogenic Diet, Fasting & Fenbendazole Published – Sept 2024 @ivermectincure The 7-Therapeutic Hybrid Model for Cancer Treatment 1. Vitamin C 2. Vitamin D 3. Zinc 4. Ivermectin 5. Fenbendazole, Mebendazole & DON (Glutamine Antagonist) 6. Fasting, Ketogenic Diet & Ketone Metabolic Therapy 7. Press-Pulse Therapy, Endurance Exercise, Hyperbaric Oxygen Therapy, Methylene Blue, CoQ10, Niacin, Magnesium & Vitamin E All dosages for these seven components are outlined in the protocol and are recommended to be followed for at least 12 weeks, regardless of cancer type. Visit: Ivermectincure.us Experimental at best, not standard care. #Ivermectin #Fenbendazole #Cancer #CancerResearch #Mebendazole